Skip to main content
65°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aveo Pharmaceuticals
(NQ:
AVEO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 19, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
14.99 (49)
Ask (Size)
15.00 (111)
Prev. Close
15.00
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
34,373,995
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 28, 2024
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 25, 2024
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
Performance
More News
Read More
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
February 06, 2024
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout
October 18, 2022
Via
Investor's Business Daily
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
January 16, 2024
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
LG Chem Completes Acquisition of AVEO Oncology
January 19, 2023
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
AVEO Oncology Stockholders Approve Acquisition by LG Chem
January 05, 2023
From
AVEO Pharmaceuticals, Inc.
Via
GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Via
MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Altra Industrial Motion Corp. (Nasdaq - AIMC), UserTesting, Inc. (NYSE - USER), AVEO Pharmaceuticals, Inc. (Nasdaq - AVEO), Limestone Bancorp, Inc. (Nasdaq - LMST)
October 31, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Via
Benzinga
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
October 24, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Via
Benzinga
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
October 19, 2022
Via
Benzinga
Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday
October 19, 2022
Via
Benzinga
AVEO ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AVEO Oncology - AVEO
October 18, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Crude Oil Drops Over 2%; Akouos Shares Spike Higher
October 18, 2022
Via
Benzinga
Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views
October 18, 2022
Via
Benzinga
Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session
October 18, 2022
Via
Benzinga
Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote
October 18, 2022
Via
InvestorPlace
Looking Into AVEO Pharmaceuticals's Recent Short Interest
October 18, 2022
Via
Benzinga
Why Is Ra Medical (RMED) Stock Up 25% Today?
October 18, 2022
Via
InvestorPlace
US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points
October 18, 2022
Via
Benzinga
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
Via
InvestorPlace
Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18
October 18, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.